RadNet, Inc. (NASDAQ:RDNT) is a prominent player in the outpatient diagnostic imaging services and digital health solutions sector. The company is known for its extensive network of imaging centers and innovative digital health offerings. In a competitive landscape, RadNet stands out with its focus on integrating advanced technology into healthcare services.
On November 10, 2025, RadNet reported earnings per share (EPS) of $0.20, which was below the expected $0.23. Despite this, the company surpassed revenue expectations, generating $522.9 million against the estimated $494 million. This revenue marks a 13.4% increase from the $461.1 million reported in the same quarter of 2024.
The Digital Health segment played a crucial role in RadNet's revenue growth, with a 51.6% increase, reaching $24.8 million compared to $16.4 million in the previous year. This segment's Adjusted EBITDA also grew by 6.9% to $3.5 million, contributing to the overall rise in the company's Adjusted EBITDA by 15.2% to $84.9 million.
RadNet's financial health is further highlighted by its improved Adjusted EBITDA margins, which increased by 26 basis points to 16.2%. The company has revised its 2025 financial guidance upwards, reflecting confidence in its growth prospects.
Despite the negative earnings, RadNet maintains a strong liquidity position with a current ratio of approximately 2.00. This suggests that the company has twice as many current assets as current liabilities, ensuring it can meet short-term obligations. The debt-to-equity ratio of about 1.97 indicates a reliance on debt, but the company's robust revenue growth and liquidity provide a solid foundation for future performance.
